drug class of nifedipine
Dihydropyridine calcium channel blocker (CCB)
Antihypertensive, antianginal
mechanism of action nifedipine
L-type voltage-gated Ca²⁺ channels (in vascular smooth muscle)
Inhibits Ca²⁺ influx → vasodilation
Little/no effect on SA or AV node
↓ Peripheral vascular resistance → ↓ BP
Reflex tachycardia may occur
pharmacokinetics of nifedipine
A; oral
D;
M; hepatic
E; renal and fecal
clinical application of Nifedipine
Angina
HTN
Raynauds
Prinsmetal angina
preterm labour
drug class of verapamil
Non-dihydropyridine CCB
Phenylalkylamine subclass
Acts mainly on cardiac muscle & nodal tissue
mechanism of action of verapamil
L type Ca channels - blocks both activated and inactivated channels
decrease Ca influx
‘cardiac’ Ca blocker
Greatly slows AV node conduction
reduces mycardial oxygen demand
clinical use of verapamil
SVT/AF
HTN
angina
migraine
toxic effect of verapamil
dose related
hypotension
bradycardia
AV block
cardiac arrest when given for VT
constipation
drug class of diltiazem
Non-dihydropyridine calcium channel blocker (CCB)
Benzothiazepine subclass
mechanism of action of Diltiazem
L type voltage gated Ca channels
decrease Ca influx
‘cardiac’ C a channel blocker
Balanced cardiac + vascular effects
Less potent at slowing conduction than verapamil, but better tolerated